Literature DB >> 21274736

Correlation between endoscopic macroscopic type and invasion depth for early esophagogastric junction adenocarcinomas.

Ichiro Oda1, Seiichiro Abe, Chika Kusano, Haruhisa Suzuki, Satoru Nonaka, Shigetaka Yoshinaga, Hirokazu Taniguchi, Tadakazu Shimoda, Takuji Gotoda.   

Abstract

BACKGROUND: Although correlations between endoscopic macroscopic type and tumor depth have been reported for superficial esophageal squamous cell carcinoma and early gastric and early colorectal adenocarcinomas, there is no published study investigating the correlation between endoscopic macroscopic type and invasion depth for mucosal (M) and submucosal (SM) adenocarcinomas located at the esophagogastric junction (EGJ). We decided to analyze, therefore, the relationship between endoscopic macroscopic type and tumor depth for such cancers.
METHODS: We retrospectively reviewed 73 early EGJ adenocarcinomas (M/SM = 33/40; differentiated/undifferentiated type = 70/3) in 73 consecutive patients treated endoscopically and/or surgically between January 2000 and December 2008. The mean age of the patients was 63.9 years (range 37-85 years) and the male/female ratio was 62:11. EGJ adenocarcinoma was defined as junctional carcinoma (type II) according to the Siewert classification.
RESULTS: We found polypoid type lesions (0-I) in 14 patients, non-polypoid type without mixed type (0-IIa, 0-IIb, or 0-IIc) in 39, and mixed type (0-IIa + IIc or 0-IIc + IIa) in 20 patients. Non-polypoid type without mixed type (31%; 12/39) lesions had a significantly lower risk for SM invasion compared to polypoid type (79%; 11/14; p < 0.01) and mixed type (85%; 17/20; p < 0.01) lesions. In polypoid type lesions, the risk of SM invasion was significantly lower for the pedunculated subtype (0-Ip) than for the sessile subtype (0-Is) lesions (0%; 0/2 vs. 92%; 11/12; p < 0.05). M lesions (mean size 14.5 ± 7.5 mm) were significantly smaller than SM lesions (24.5 ± 7.7 mm; p < 0.01).
CONCLUSIONS: Determination of endoscopic macroscopic type may be useful in accurately diagnosing early EGJ adenocarcinoma invasion depth.

Entities:  

Mesh:

Year:  2011        PMID: 21274736     DOI: 10.1007/s10120-011-0001-0

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  23 in total

Review 1.  The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002.

Authors: 
Journal:  Gastrointest Endosc       Date:  2003-12       Impact factor: 9.427

Review 2.  Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract.

Authors:  Roy Soetikno; Tonya Kaltenbach; Ronald Yeh; Takuji Gotoda
Journal:  J Clin Oncol       Date:  2005-07-10       Impact factor: 44.544

Review 3.  A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma.

Authors:  S Kelly; K M Harris; E Berry; J Hutton; P Roderick; J Cullingworth; L Gathercole; M A Smith
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

4.  Relation between endoscopic ultrasound findings and outcome of patients with tumors of the esophagus or esophagogastric junction.

Authors:  M Hiele; P De Leyn; P Schurmans; A Lerut; S Huys; K Geboes; A M Gevers; P Rutgeerts
Journal:  Gastrointest Endosc       Date:  1997-05       Impact factor: 9.427

5.  Successful outcomes of a novel endoscopic treatment for GI tumors: endoscopic submucosal dissection with a mixture of high-molecular-weight hyaluronic acid, glycerin, and sugar.

Authors:  Mitsuhiro Fujishiro; Naohisa Yahagi; Masanori Nakamura; Naomi Kakushima; Shinya Kodashima; Satoshi Ono; Katsuya Kobayashi; Takuhei Hashimoto; Nobutake Yamamichi; Ayako Tateishi; Yasuhito Shimizu; Masashi Oka; Keiji Ogura; Takao Kawabe; Masao Ichinose; Masao Omata
Journal:  Gastrointest Endosc       Date:  2006-02       Impact factor: 9.427

6.  A multicenter retrospective study of endoscopic resection for early gastric cancer.

Authors:  Ichiro Oda; Daizo Saito; Masahiro Tada; Hiroyasu Iishi; Satoshi Tanabe; Tsuneo Oyama; Toshihiko Doi; Yoshihide Otani; Junko Fujisaki; Yoichi Ajioka; Tsutomu Hamada; Haruhiro Inoue; Takuji Gotoda; Shigeaki Yoshida
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

7.  Prospective evaluation of the macroscopic types and location of early Barrett's neoplasia in 380 lesions.

Authors:  O Pech; L Gossner; H Manner; A May; T Rabenstein; A Behrens; M Berres; J Huijsmans; M Vieth; M Stolte; C Ell
Journal:  Endoscopy       Date:  2007-07       Impact factor: 10.093

8.  Successful en-bloc resection of large superficial tumors in the stomach and colon using sodium hyaluronate and small-caliber-tip transparent hood.

Authors:  H Yamamoto; H Kawata; K Sunada; A Sasaki; K Nakazawa; T Miyata; Y Sekine; T Yano; K Satoh; K Ido; K Sugano
Journal:  Endoscopy       Date:  2003-08       Impact factor: 10.093

9.  Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction.

Authors:  Shigetaka Yoshinaga; Takuji Gotoda; Chika Kusano; Ichiro Oda; Kazuhiko Nakamura; Ryoichi Takayanagi
Journal:  Gastrointest Endosc       Date:  2008-02       Impact factor: 9.427

10.  Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden.

Authors:  L E Hansson; P Sparén; O Nyrén
Journal:  Int J Cancer       Date:  1993-05-28       Impact factor: 7.396

View more
  13 in total

1.  Value of splenectomy in patients with Siewert type II adenocarcinoma of the esophagogastric junction.

Authors:  Hironobu Goto; Masanori Tokunaga; Norihiko Sugisawa; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Masahiro Niihara; Yasuhiro Tsubosa; Masanori Terashima
Journal:  Gastric Cancer       Date:  2012-11-18       Impact factor: 7.370

2.  Clinical implication of endoscopic gross appearance in superficial esophageal squamous carcinoma: revisited.

Authors:  Cheal Wung Huh; Da Hyun Jung; Jie-Hyun Kim; Dae Won Ma; Young Hoon Youn; Hyojin Park
Journal:  Surg Endosc       Date:  2017-06-29       Impact factor: 4.584

3.  Lymph node metastasis and lymphadenectomy of resectable adenocarcinoma of the esophagogastric junction.

Authors:  Xin-Zu Chen; Wei-Han Zhang; Jian-Kun Hu
Journal:  Chin J Cancer Res       Date:  2014-06       Impact factor: 5.087

4.  Prognostic Impact of Splenectomy in Patients with Esophagogastric Junction Carcinoma.

Authors:  Minoru Fukuchi; Erito Mochiki; Toru Ishiguro; Kana Saito; Hiroshi Naitoh; Youichi Kumagai; Keiichiro Ishibashi; Hideyuki Ishida
Journal:  In Vivo       Date:  2018 Jan-Feb       Impact factor: 2.155

5.  A model based on endoscopic morphology of submucosal esophageal squamous cell carcinoma for determining risk of metastasis on lymph nodes.

Authors:  Lingdun Zhuge; Shengfei Wang; Juntao Xie; Binhao Huang; Difan Zheng; Shanbo Zheng; Hengyu Mao; Arjun Pennathur; Manuel Villa Sanchez; James D Luketich; Jiaqing Xiang; Haiquan Chen; Jie Zhang
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

6.  Efficacy analysis of Cheng's GIRAFFE reconstruction after proximal gastrectomy for adenocarcinoma of esophagogastric junction.

Authors:  Zhiyuan Xu; Can Hu; Yanqiang Zhang; Ling Huang; Litao Yang; Jianfa Yu; Pengfei Yu; Jiahui Chen; Yian Du; Xiangdong Cheng
Journal:  Chin J Cancer Res       Date:  2022-06-30       Impact factor: 4.026

7.  Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with Siewert type II/III early gastric cancer.

Authors:  Jeung Hui Pyo; Hyuk Lee; Yang Won Min; Byung-Hoon Min; Jun Haeng Lee; Kyoung-Mee Kim; Heejin Yoo; Soohyun Ahn; Jae J Kim
Journal:  Gastric Cancer       Date:  2017-12-14       Impact factor: 7.370

8.  The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients.

Authors:  Hironobu Goto; Masanori Tokunaga; Yuichiro Miki; Rie Makuuchi; Norihiko Sugisawa; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Masahiro Niihara; Yasuhiro Tsubosa; Masanori Terashima
Journal:  Gastric Cancer       Date:  2014-03-22       Impact factor: 7.370

9.  Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction.

Authors:  Lidan Sun; Fei Chen; Wenna Shi; Lei Qi; Zhongmei Zhao; Jianping Zhang
Journal:  Diagn Pathol       Date:  2014-07-16       Impact factor: 2.644

10.  Effective optical identification of type "0-IIb" early gastric cancer with narrow band imaging magnification endoscopy, successfully treated by endoscopic submucosal dissection.

Authors:  Nikolas Eleftheriadis; Ηaruhiro Inoue; Haruo Ikeda; Manabu Onimaru; Akira Yoshida; Roberta Maselli; Grace Santi; Shigeharu Hamatani; Shin-Ei Kudo
Journal:  Ann Gastroenterol       Date:  2015 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.